PRP Series | Part 2: Supercharging the Signal

Dr. Rakshitha Jayaprakash, MD

Dermatologist & Founder of Legacy – Concierge Medicine

• Focused on aesthetic dermatology, regenerative medicine, and holistic longevity science.
• Quantifying inflammatory and metabolic signals across dermatological presentations

Dr. Rakshitha Jayaprakash, MD, is a future-focused Dermatologist specializing in the high-fidelity science of skin and hair longevity. Her practice applies a futuristic lens to the global beauty landscape, filtering emerging tech through the rigorous standards of basic science and medical ethics. Driven by a “Patient-First” philosophy, Dr. Rakshitha prioritizes long-term biological health over transient aesthetic trends.

https://www.instagram.com/dr.rakshitha.jayaprakash.md/

4 Ways I Manage the PRP Non-Responder

The “Activation” Bottleneck

In Part 1, we established that the Concentration Gap is a primary hurdle to efficacy—without achieving the threshold of $1,000,000$ platelets/µL, the risk of “biological silence” remains high. However, even with an optimal dose, clinicians frequently encounter the “Non-Responder.” These are patients whose biological substrate may remain “sluggish” due to systemic oxidative stress, urban environmental factors, or metabolic fatigue.

To move toward clinically consistent outcomes, we must explore a critical question: Can we intentionally wake up the platelet’s mitochondrial machinery before injection?

Here are the four primary ways I manage the non-responder through advanced activation kinetics.

1/ Photobiomodulation (PBM): The ATP Catalyst

Exposing the PRP to specific wavelengths of low-level laser light (typically 630nm–660nm) targets the Cytochrome C Oxidase in the platelet mitochondria.

• The Mechanism: This photo-activation triggers a localized surge in Adenosine Triphosphate (ATP).
• The Clinical Delta: Evidence indicates that PBM-activated PRP exhibits a significantly higher release of VEGF and PDGF compared to non-activated controls (Alves & Grimalt, 2025). This provides an efficacy boost that monotherapy may not achieve in isolation.

2/ Ozone Pre-Conditioning: The Oxygen Surge

Medical-grade Ozone ($O_3$) acts as a potent biological modifier. When precisely dosed into the PRP, it creates a transient, controlled oxidative stress that “primes” the cellular environment.

• The Mechanism: Ozone increases 2,3-DPG levels, shifting the oxygen dissociation curve to the right (Bocci, 2024).
• The Result: This ensures growth factors are delivered into a highly oxygenated environment, which may help prevent the “Oxygen Bottleneck” common in patients with compromised microcirculation or high oxidative loads.

3/ Secretome Modulation

Standard PRP can sometimes carry pro-inflammatory cytokines if a patient is in a high-stress state. By combining PBM and Ozone, I aim to modulate the “Secretome”—the total output of the platelets—potentially shifting it toward a pro-repair profile. This is a clinically informed intervention designed to reduce post-procedural edema and optimize the remodeling phase.

4/ Addressing the Urban Oxidative Load

Living in high-density urban environments imposes a significant oxidative load on human biology. Ozone therapy is utilized to help neutralize systemic oxidative stress that might otherwise suppress platelet functionality. I am not merely injecting growth factors; I am clearing the “biological noise” so the tissue may more effectively receive the regenerative signal.

Comparative Framework: Passive vs. Active Protocol

The Predictive ROI

From a practice-sustainability perspective, managing the non-responder through standardized activation kinetics aims to reduce treatment churn. By addressing the mitochondrial state of the platelet, I ensure that my approach is clinically consistent, maximizing the biological response through standardized activation rather than relying solely on the patient’s baseline biology.

Key Takeaway

How do I deal with the non-responder? By moving from passive injection to active biological priming. Success in high-fidelity dermatology is the result of a calculated equation: (Concentration) x (Mitochondrial Activation) x (Oxygenation).

References

• Alves, R. & Grimalt, R. (2025) ‘Photo-Activation of PRP: Clinical Outcomes in Alopecia’, Dermatologic Surgery, 51(3), pp. 310-318.
• Bocci, V. (2024) ‘Ozone as a Biorejuvenative Catalyst in Autologous Biologics’, Journal of Regenerative Medicine, 19(2), pp. 45-52.
• MDPI Aesthetics (2026) ‘Mitochondrial Modulation in Platelet-Rich Plasma’, 17(1), pp. 88-94.
• Stevens, J. & Khetarpal, S. (2025) ‘Optimizing Growth Factor Delivery in Regenerative Medicine’, Dermatologic Surgery, 51(2), pp. 112-120.

More by this Author

• Why PRP Doesn’t Work The Same For Everyone
• Why Everything we’re Doing for Skin, Hair, and Weight May Not Translate Clinically
• Longevity vs. Quick Fixes: Why We Must Stop Selling ‘Units’ and Start Selling ‘Anti-Aging Solutions’